Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Leukocyte Disorders » Leukopenia » Agranulocytosis » Neutropenia
Description
A decrease in the number of NEUTROPHILS found in the blood. MeSH
Hierarchy View
Subtype Terms (1)
Febrile Neutropenia
39 drugs (32 approved, 7 experimental)
Approved Indicated Drugs (4)
Phase 3 Indicated Drugs (37)
Phase 2 Indicated Drugs (35)
Phase 1 Indicated Drugs (13)
Other Experimental Indicated Drugs (11)
Organization Involved with Phase 4 Indications (51)
Anglo Celtic Cooperative Oncology Group
Belarusian State Medical University
Minsk State Clinical Hospital No 9
National Institute of Allergy and Infectious Diseases (NIAID)
National Institutes of Health (NIH)
Scottish Cancer Therapy Network
Shijiazhuang Pharma Group (CSPC)
Organization Involved with Phase 3 Indications (85)
Bangalore Institute of Oncology
BeyondSpring Pharmaceuticals Inc.
Center for Supporting Hematology-Oncology Trials
Donetsk City Municipal Oncology Dispensary
Donetsk Regional oncology centers
European Organisation for Research and Treatment of Cancer
Froedtert Memorial Lutheran Hospital
Hospital Regional Alta Especialidad Bajio
Huazhong University of Science and Technology
Kharkiv Regional Clinical Oncology Center
M.S. Ramaiah Medical College, Bangalore, India
National Cancer Institute (NCI)
Non-State Healtcare Institution Road Clinical Hospital of Open Joint Stock Company Russian Railways
QUID Quality in Drugs and Devices Latin American Consulting SRL
Russian Academy of Medical Sciences
Organization Involved with Phase 2 Indications (73)
Arizona Center for Cancer Care
California Cancer Assocaties for Research & Excellence
City of Hope National Medical Center
Department of Health and Human Services
Good Samaritan Hospital, Corvallis
Hangzhou Jiuyuan Gene Engineering Co. Ltd.,
Inner Mongolia Medical University
National Autonomous University of Mexico
National Polytechnic Institute, Mexico
Oregon Health and Science University
Republican Endocrinology Center Hospital, Minsk, Republic of Belarus
State University of New York, Buffalo
St.-Petersburg State Budgetary Healtcare Institution City Clinical Oncological Dispensary
Organization Involved with Phase 1 Indications (16)
Organization Involved with Other Experimental Indications (11)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.